Physician profile
Amy E Mccollum
NPI 1811959679
$866.47
in general payments reported to CMS, 2019-2025
15 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $49.59 · 2022: $65.84 · 2023: $115 · 2024: $189 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $310.74 | 2022-2025 | Azstarys |
| Pfizer INC. | $118.15 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $74.07 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Glaxosmithkline, LLC. | $68.25 | 2019-2024 | Bexsero |
| Sanofi Pasteur INC. | $47.37 | 2023-2025 | |
| Shire North American Group INC | $39.82 | 2019 | |
| Genentech USA, INC. | $34.83 | 2019 | |
| Neos Therapeutics, LP | $32.11 | 2019 | |
| Biomarin Pharmaceutical INC. | $25.38 | 2025 | Voxzogo 1.2mg |
| Tris Pharma INC | $24.44 | 2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $21.09 | 2019 | |
| Neurelis, INC. | $20.92 | 2024 | Valtoco |
| Sobi, INC | $17.34 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.85 | 2024 | Flumist Quadrivalent |
| Seqirus USA INC | $15.11 | 2025 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mccollum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.